Insulin treatment reduces the increased serum and lung angiotensin converting enzyme activity in streptozotocin-induced diabetic rats

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 58, Issue 1, 1998, Pages 81-88

  Erman, A ^a,b   Chen Gal, B ^a   David, I ^a   Giler, S ^a   Boner, G ^a   Van Dijk, D J ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Diabetes; Kininase II

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFECT; ENZYME ACTIVITY; INSULIN TREATMENT; LUNG; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; SERUM;

ANIMALIA;

EID: 0031933778     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519850186869     Document Type: Article

References (16)

1. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1982; 19: 410-15.
2. Zatz R, Meyer TW, Anderson S, Rennke HG, Brenner BM. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proe Nat Acad Sci USA 1985; 82: 5963-7.
3. Yaun BH, Robinette JB, Conger JD. Effect of angiotensin II and norepinephrine on isolated rat afferent arterioles. Am J Physiol 1990; 258: F741-F750.
4. Errmin A, van Dyk DJ, Chen-Gal B, Iskera D, Oiler S, Rosenfeld JB, Boner O. Angiotensin converting enzyme activity in the scrum, lung and kidney of diabetic rats. Eur J Clin Invest 1993; 23: 615-20.
5. Valentovic MA, Elliott CW, Ball JG. The effect of streptozotocin-induced diabetes and insulin treatment on angiotensin converting enzyme activity. Res Commun Chem Pathol Pharmacol 1987; 58: 27-38.
6. Anderson S, Jung FF, Ingelfinger JR. Renal renin-angiotensin system in diabetes: functional, immunohistochemical. and molecular biological correlations. Am J Physiol 1993; 265: F477-F486.
7. van Dyk DJ, Erman A, Erman T, Chen-Gal B, Sulkes J, Boner G. Increased serum angiotensin converting enzyme activity in type I diabetic patients. Eur J Clin Invest 1994; 24: 463-7.
8. Erman A, Chen-Gal B, Zabludowski J, Rosenfeld JB. Cyclosporine A treatment enhances angiotensin converting enzyme activity in lung and serum of rats. J Pharm Pharmacol 1990; 42: 425-7.
9. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin reagent. J Chem Biol 1951; 193: 265-75.
10. Bradford AA. A rapid and sensitive method for the quatitation of microgram quantities of protein utilizing the principle of dye binding. Ann Biochem 1976; 72: 248-54.
11. Christlieb AR, Long R, Underwood RH. Renin-angiotensin-aldosterone system, electrolyte homeostasis and blood pressure in alloxan diabetes. Am J Med Sci 1979; 277: 295-303.
12. Christlieb AR, Renin, angiotensin. and norepinephrine in alloxan diabetes. Diabetes 1974; 23: 962-70.
13. Flordal PR. The plasma dilution factor: Predicting how concentrations in plasma and serum are affected by blood volume variations and blood loss. J Lab Clin Med 1995; 126: 353-7.
14. Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990; 16: 363-70.
15. Correa-Rotter R, Hostetter TH, Rosenberg ME. Renin and angiotensinogen gene expression in experimental diabetes mellitus. Kidney Int 1992; 41: 796-804.
16. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925-30.